Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05319158

The Effect of the Movement Imitation Therapy in Preterm (MIT-PB) in Motor Behavior's Quality.

The Effect of the Movement Imitation Therapy for Preterm Babies (MIT-PB) on Motor Behavior Quality. Quasi-experimental Design.

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
36 (estimated)
Sponsor
Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta · Academic / Other
Sex
All
Age
22 Weeks – 32 Weeks
Healthy volunteers
Not accepted

Summary

This study aims to assess the effect of a parent-administered intervention program based on MIT-PB in preterm with abnormal general movements during the preterm period. We will describe the short and long-term differences between infants exposed to MIT-PB and infants who follow current standard care.

Detailed description

The quasi-experimental design has been planned to assess the effect of a physiotherapy program carried out in neonatal intensive care and at home during the first months of life. Preterm babies born before 32 weeks gestational age (GA) and/or with less than 1500g showing an abnormal General Movement Assessment (GMA) at 34-36 weeks will be included. Standardized tests will be performed at baseline, at term, 44 weeks post-menstrual age (PMA), 54 weeks PMA, 6 months, and 12 months. A qualitative study has been designed to assess the physiotherapy performance and parents' experience. Three different Hospitals with similar care protocols and sizes will recruit the sample (n=36). The Intervention groups (n=18) will be located at Hospital Josep Trueta of Girona and Hospital Sant Joan de Déu and the control group (n=18) will be located at Hospital Parc Taulí of Sabadell (Barcelona).

Conditions

Interventions

TypeNameDescription
OTHERMIT-PB, movement imitation therapy for preterm.The instant an infant showed CS or PR movements, the therapists (or a therapist and a parent) intervened by gently guiding the infants' limbs so as to maneuver and smoothen their movements, thereby imitating normal GM sequences as closely as possible, adding variability to the movement

Timeline

Start date
2022-04-04
Primary completion
2026-03-31
Completion
2027-03-31
First posted
2022-04-08
Last updated
2024-12-10

Locations

3 sites across 1 country: Spain

Source: ClinicalTrials.gov record NCT05319158. Inclusion in this directory is not an endorsement.